Skip to content

Released Nov 10, 2014, before the open

10-Q filed Nov 10, 2014, 41 days after period end · 0001144204-14-066218

Q3 2014 · 10-Q
Revenue—
Net Income-$4.09MN/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$0.32N/M vs Q3 2013N/M vs Q2 2014
Operating Income-$4,118,351N/M
Operating Cash Flowderived-$2,477,175N/M
Free Cash Flowderived-$2,496,589N/M

What the release said

The release

Same quarter

MetricQ3 2014Q3 2013Q3 2012Q3 2011
Revenue—$0.00$0.00$0.00
Net Income-$4.09M-$3.48M-$1.01M$0.00
EPS Diluted-$0.32-$0.39-$0.23$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR